Expression of skin-derived antileukoproteinase (SKALP) in reconstructed human epidermis and its value as a market for skin irritation

Acta Dermato-Venereologica

Volumn 78, Issue 2, 1998, Pages 107-113

  Boelsma, Esther ^a   Gibbs, Susan ^a   Ponec, Maria ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Culture conditions; Immunohistochemistry; Oleic acid; Sodium lauryl sulfate

Indexed keywords

ALITRETINOIN; ALPHA TOCOPHEROL; ASCORBIC ACID; CALCITRIOL; DODECYL SULFATE SODIUM; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; OLEIC ACID; PROTEINASE INHIBITOR; RETINOIC ACID; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR ALPHA; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN IRRITATION;

BIOLOGICAL MARKERS; BLOTTING, NORTHERN; DERMATITIS, ALLERGIC CONTACT; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IRRITANTS; OLEIC ACID; PROTEIN BIOSYNTHESIS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; SERINE PROTEINASE INHIBITORS; SKIN; SODIUM DODECYL SULFATE; VITAMINS;

EID: 0031966403     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598433421     Document Type: Article

References (29)

1. Nickoloff BJ, Turka LA. Keratinocytes: key immunocytes of the integument. Am J Pathol 1993; 143: 325-331.
2. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994: 15; 74-80.
3. Schalkwijk J, Chang A, Janssen P, de Jongh GJ, Mier PD. Skin-derived antileukoproteinases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol 1990; 122: 631-641.
4. Wiedow O, Lüdemann J, Utrecht B. Elafin is a potent inhibitor of proteinase-3. Biochem Biophys Res Comm 1991; 174: 6-10.
5. Schalkwijk J, van Vlijmen IMJJ, Alkemade JAC, de Jongh GJ. Immunohistochemical localization of SKALP/Elafin in psoriatic epidermis. J Invest Dermatol 1993; 100: 390-393.
6. Alkemade JAC, Molhuizen HOF, van Vlijmen-Willems IMJJ, van Haelst UJGM, Schalkwijk J. Differential expression of SKALP Elafin in human epidermal tumors. Am J Path 1993; 143: 1679-1687.
7. Ponec M. Reconstruction of human epidermis on de-epidermized dermis: expression of differentiation-specific protein markers and lipid composition. Toxic in Vitro 1991; 5: 597-606.
8. Ponec M, Gibbs S, Weerheim A, Kempenaar J, Mulder A, Mommaas AM. Epidermal growth factor and temperature regulate keratinocyte differentiation. Arch Dermatol Res, 1997; 289: 317-326.
9. Gibbs S, Vicanova J, Bouwstra J, Valstar I, Kempenaar J, Ponec M. Culture of reconstructed epidermis in a defined medium at 33°C shows a delayed epidermal maturation, prolonged lifespan and improved stratum corneum. Arch Dermatol Res 1997; 289: 585-595.
10. Ponec M, Havekes L, Kempenaar J, Lavrijsen S, Wijsman M, Boonstra J, et al. Calcium-mediated regulation of the low density lipoprotein receptor and intracellular cholesterol synthesis in human epidermal keratinocytes. J Cell Physiol 1985; 125: 98-106.
11. Régnier M, Pruniéras M, Woodley D. Growth and differentiation of adult human epidermal cells on dermal substrates. Frontiers Matrix Biol 1981; 9: 4-35.
12. Boyce ST, Williams ML. Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin. J Invest Dermatol 1993; 101: 180-184.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
14. Ponec M, Kempenaar J. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol 1995; 8: 49-59.
15. Boelsma E, Tanojo H, Boddé HE, Ponec M. Assessment of the potential irritancy of oleic acid on human skin: evaluation in vitro and in vivo. Toxic in Vitro 1996; 10: 729-742.
16. Boelsma E, Tanojo H, Boddé HE, Ponec M. An in vivo-in vitro study to the use of a human skin equivalent for irritancy screening of fatty acids. Toxic in Vitro 1997; 11: 365-376.
17. Chang A, de Jongh GJ, Mier PD, van de Kerkhof PCM. Enzymatic quantification of polymorphonuclear leukocytes in normal and psoriatic skin following standard injury. Clin Exp Dermatol 1988; 13: 62-66.
18. Lammers AM, van de Kerkhof PCM. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin. Br J Dermatol 1987; 116: 521-524.
19. Briggaman RA, Schechter NM, Fräki J, Lazarus GS. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 1984; 160: 1027-1042.
20. Alkemade JAC, Molhuizen HOF, Ponec M, Kempenaar JA, van Zeeuwen PLJ, de Jongh GJ, et al. SKALP elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Science 1994; 107: 2335-2342.
21. van Ruissen F, de Jongh GJ, Zeeuwen PLJM, van Erp PEJ, Madsen P, Schalkwijk J. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol 1996; 168: 442-452.
22. Hudson LC, Gill GN. Regulation of gene expression by epidermal growth factor. In: Genetic engineering, principles and methods. New York: Plenum Press: Vol 1991; 13: 137-152.
23. Cha D, O'Brien P, O'Toole EA, Woodley DT, Hudson LG. Enhanced modulation of keratinocyte motility by transforming growth factor-α (TGFα) relative to epidermal growth factor. Cell 1996; 50: 1131-1137.
24. Gibbs S, Boelsma E, Kempenaar J, Ponec M. EGF and TGFα differentially regulate epidermal morphogenesis and the expression of cornified envelope precursors. Cell Tissue Res, in press.
25. Ponec M, Weerheim A, Kempenaar J, Mulder A, Gooris GS, Bouwstra J, et al. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997; 109: 348-355.
26. Régnier M, Darmon M. Human epidermis reconstructed in vitro: a model to study keratinocyte differentiation and its modulation by retinoic acid. In Vitro Cell & Dev Biol 1989; 25: 1000-1008.
27. Smith EL, Walworth NC, Holick MF. Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-714.
28. Gibbs S, Backendorf C, Ponec M. Regulation of keratinocyte proliferation and differentiation by all-trans-retinoic acid. 9-cis-retinoic acid and 1,25-dihydroxy vitamin D3. Arch Dermatol Res 1996; 288: 729-738.
29. Coulomb B, Lebreton, C, Dubertret L. Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol 1989; 92: 122-125.